Home Tags DT2219ARL

Tag: DT2219ARL

University of Minnesota Masonic Cancer Center Proceeds With Development Novel Leukemia...

Scientists at the University of Minnesota Masonic Cancer Center have received notification from the U.S. Food and Drug Administration (FDA) that they can proceed...